RU2003123493A - NEUROTROAN ANALOGUES OF TACROLIMUS - Google Patents
NEUROTROAN ANALOGUES OF TACROLIMUS Download PDFInfo
- Publication number
- RU2003123493A RU2003123493A RU2003123493/15A RU2003123493A RU2003123493A RU 2003123493 A RU2003123493 A RU 2003123493A RU 2003123493/15 A RU2003123493/15 A RU 2003123493/15A RU 2003123493 A RU2003123493 A RU 2003123493A RU 2003123493 A RU2003123493 A RU 2003123493A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- nerve
- damage
- spinal cord
- disease
- Prior art date
Links
- VFIDUYNRGWCMOF-TVZBMWKJSA-N CC(CC1OC)C(C(C(C(CCC2C3)=CC3COOC(C(C)C(CC(C(CC(C)=O)/C=C(\C)/CC(C)C3)=O)O)/C2=C/C(CCC2O)CC2OC)=O)O)(O)OC1C3OC Chemical compound CC(CC1OC)C(C(C(C(CCC2C3)=CC3COOC(C(C)C(CC(C(CC(C)=O)/C=C(\C)/CC(C)C3)=O)O)/C2=C/C(CCC2O)CC2OC)=O)O)(O)OC1C3OC VFIDUYNRGWCMOF-TVZBMWKJSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Packages (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Claims (42)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25850000P | 2000-12-29 | 2000-12-29 | |
US60/258,500 | 2000-12-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2003123493A true RU2003123493A (en) | 2005-01-20 |
RU2288716C2 RU2288716C2 (en) | 2006-12-10 |
Family
ID=22980816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003123493/15A RU2288716C2 (en) | 2000-12-29 | 2001-12-31 | Neurotropic tacrolimus analogs |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1353671A4 (en) |
JP (1) | JP2004527472A (en) |
KR (2) | KR20070030331A (en) |
CN (1) | CN1293877C (en) |
AR (1) | AR035411A1 (en) |
AU (1) | AU2002231277B2 (en) |
BR (1) | BR0116762A (en) |
CA (1) | CA2433384A1 (en) |
CZ (1) | CZ20032060A3 (en) |
HU (1) | HUP0302521A3 (en) |
IL (1) | IL156664A0 (en) |
MX (1) | MXPA03005941A (en) |
NO (1) | NO20032913D0 (en) |
NZ (1) | NZ527209A (en) |
PL (1) | PL366301A1 (en) |
RU (1) | RU2288716C2 (en) |
WO (1) | WO2002053159A1 (en) |
ZA (1) | ZA200305806B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003901023A0 (en) * | 2003-03-04 | 2003-03-20 | Fujisawa Pharmaceutical Co., Ltd. | New use |
CA2554045A1 (en) * | 2004-01-20 | 2005-07-28 | Astellas Pharma Inc. | Method for treating erectile dysfunction |
EP1810675A1 (en) * | 2006-01-18 | 2007-07-25 | Institut Curie | Method for treating Huntington's disease by inhibiting dephosphorylation of huntingtin at S421 |
JP2009102226A (en) * | 2006-02-14 | 2009-05-14 | Meiji Milk Prod Co Ltd | Therapeutic agent for spinal cord injury |
JP5878015B2 (en) * | 2008-07-23 | 2016-03-08 | ノバルティス アーゲー | Sphingosine monophosphate receptor modulators and their use to treat muscle inflammation |
JP2015511242A (en) * | 2012-02-23 | 2015-04-16 | インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラリシェルシェ メディカル) | Calcineurin inhibitors for use in the treatment of pathological vestibular disorders |
GB201309375D0 (en) * | 2013-05-24 | 2013-07-10 | Chronos Therapeutics Ltd | Medical methods and compounds for medical use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2799208B2 (en) * | 1987-12-09 | 1998-09-17 | フアイソンズ・ピーエルシー | Macrocyclic compound |
GR1001225B (en) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Novel macrocyclic compositions and new application method thereof |
US5541193A (en) | 1991-09-05 | 1996-07-30 | Abbott Laboratories | Heterocycle-containing macrocyclic immunomodulators |
GB9202196D0 (en) * | 1992-02-01 | 1992-03-18 | Fisons Plc | Method of treatment |
GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
-
2001
- 2001-12-27 AR ARP010106058A patent/AR035411A1/en unknown
- 2001-12-31 BR BR0116762-6A patent/BR0116762A/en not_active Application Discontinuation
- 2001-12-31 CA CA002433384A patent/CA2433384A1/en not_active Abandoned
- 2001-12-31 PL PL01366301A patent/PL366301A1/en not_active Application Discontinuation
- 2001-12-31 HU HU0302521A patent/HUP0302521A3/en unknown
- 2001-12-31 IL IL15666401A patent/IL156664A0/en unknown
- 2001-12-31 RU RU2003123493/15A patent/RU2288716C2/en not_active IP Right Cessation
- 2001-12-31 JP JP2002554109A patent/JP2004527472A/en not_active Ceased
- 2001-12-31 CN CNB018228860A patent/CN1293877C/en not_active Expired - Fee Related
- 2001-12-31 AU AU2002231277A patent/AU2002231277B2/en not_active Ceased
- 2001-12-31 CZ CZ20032060A patent/CZ20032060A3/en unknown
- 2001-12-31 KR KR1020077003889A patent/KR20070030331A/en not_active Application Discontinuation
- 2001-12-31 NZ NZ527209A patent/NZ527209A/en unknown
- 2001-12-31 EP EP01991558A patent/EP1353671A4/en not_active Withdrawn
- 2001-12-31 MX MXPA03005941A patent/MXPA03005941A/en active IP Right Grant
- 2001-12-31 WO PCT/US2001/050419 patent/WO2002053159A1/en active IP Right Grant
- 2001-12-31 KR KR1020037008787A patent/KR100794204B1/en not_active IP Right Cessation
-
2003
- 2003-06-24 NO NO20032913A patent/NO20032913D0/en not_active Application Discontinuation
- 2003-07-28 ZA ZA2003/05806A patent/ZA200305806B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2002231277B2 (en) | 2006-11-30 |
IL156664A0 (en) | 2004-01-04 |
ZA200305806B (en) | 2005-01-26 |
EP1353671A4 (en) | 2004-07-14 |
CN1538843A (en) | 2004-10-20 |
HUP0302521A2 (en) | 2003-11-28 |
KR20040007431A (en) | 2004-01-24 |
CA2433384A1 (en) | 2002-07-11 |
EP1353671A1 (en) | 2003-10-22 |
JP2004527472A (en) | 2004-09-09 |
MXPA03005941A (en) | 2005-02-14 |
NO20032913D0 (en) | 2003-06-24 |
NZ527209A (en) | 2005-09-30 |
PL366301A1 (en) | 2005-01-24 |
KR100794204B1 (en) | 2008-01-14 |
WO2002053159A1 (en) | 2002-07-11 |
AR035411A1 (en) | 2004-05-26 |
CZ20032060A3 (en) | 2004-01-14 |
CN1293877C (en) | 2007-01-10 |
BR0116762A (en) | 2004-08-10 |
RU2288716C2 (en) | 2006-12-10 |
HUP0302521A3 (en) | 2007-03-28 |
KR20070030331A (en) | 2007-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI79554C (en) | FOERFARANDE FOER FRAMSTAELLNING AV HYALURONSYRAFRAKTIONER MED FARMACEUTISK AKTIVITET. | |
KR0178544B1 (en) | Ophthalmic pure hyaluronic acid fraction and its purification method | |
EP2717888A1 (en) | Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof | |
RU2181048C2 (en) | Use of combination of benzothiophene and progestin for treatment of osteoporosis | |
TW522012B (en) | Denaturants for sympathomimetic amine salts | |
JP2002069004A (en) | Peripheral active antalgesia opiate | |
JPH10507743A (en) | Methods and means for drug administration | |
Gwon et al. | A histologic study of lens regeneration in aphakic rabbits. | |
ES2380674B1 (en) | MESENQUIMAL CELLS AND COMPOSITE MEMBRANE FOR THE TREATMENT OF OSTEOCONDRAL INJURIES | |
CN102395275A (en) | Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles | |
RU2004132856A (en) | PHARMACEUTICAL PRODUCT WITH MODIFIED RELEASE | |
JP4436131B2 (en) | Composition for stabilizing hyaluronic acid | |
RU2003123493A (en) | NEUROTROAN ANALOGUES OF TACROLIMUS | |
Stark et al. | Reduction of pupillary constriction during cataract surgery using suprofen | |
WO2009024348A1 (en) | Method for activating regulatory t-cells | |
CN106458878B (en) | 2- cyano -3- cyclopropyl -3- hydroxy-ns-thio the acrylamide derivative of aryl - | |
CA3166379A1 (en) | Inhibitors of glutathione s-transferases (gsts) and nad(p)h:quinone oxidoreductase 1 (nqo1), pharmaceutical compositions, and uses in managing cancer | |
TW200410683A (en) | Medicament for preventing and/or treating peripheral neuropathies | |
JP2022502379A (en) | Amino acid derivatives of glucosamine that promote the synthesis of extracellular matrix, and pharmaceutical compositions containing them. | |
CA2454544A1 (en) | Optic nerve protecting agents containing .alpha.1 receptor blocker as active ingredient | |
CN105992758A (en) | Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of mps iiic | |
JP2007521285A (en) | Coumarin derivatives for the treatment of eye disorders | |
CN110859835B (en) | Application of butylphthalide in preparation of medicine for treating corneal injury | |
CN1325308A (en) | Use of neurotrophic factor stimulators for treatment of ophthalmic neurodegenerative diseases | |
CN114732947A (en) | Preparation method of femoral middle-end porous functionally-graded structure regenerated skeleton support |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20090101 |